Life sciences, as ever, remains the theme of many of this week’s investments. But the standout investment was by Xavier Niel in a Paris-based cutting-edge AI biotech group, Bioptimus. He co-invested in the startup with Nicole Junkermann’s investment group, NJF Capital.
Subscribe
You will need a Premium+ Subscription to read this article.
Exclusive news, analysis and research on global family enterprise and private investment offices
Already have an account? Sign in
Already have an account? Sign in
You've reached the end.
Continue reading free articles by registering as a Member.
Or choose a Premium Plan.
Already have an account? Sign in
